Zobrazeno 1 - 10
of 84
pro vyhledávání: '"Matthew J Memoli"'
Autor:
John H Powers, Elizabeth D Bacci, Nancy K Leidy, Jiat-Ling Poon, Sonja Stringer, Matthew J Memoli, Alison Han, Mary P Fairchok, Christian Coles, Jackie Owens, Wei-Ju Chen, John C Arnold, Patrick J Danaher, Tahaniyat Lalani, Timothy H Burgess, Eugene V Millar, Michelande Ridore, Andrés Hernández, Patricia Rodríguez-Zulueta, Hilda Ortega-Gallegos, Arturo Galindo-Fraga, Guillermo M Ruiz-Palacios, Sarah Pett, William Fischer, Daniel Gillor, Laura Moreno Macias, Anna DuVal, Richard Rothman, Andrea Dugas, M Lourdes Guerrero
Publikováno v:
PLoS ONE, Vol 13, Iss 3, p e0194180 (2018)
BackgroundThe inFLUenza Patient Reported Outcome (FLU-PRO) measure is a daily diary assessing signs/symptoms of influenza across six body systems: Nose, Throat, Eyes, Chest/Respiratory, Gastrointestinal, Body/Systemic, developed and tested in adults
Externí odkaz:
https://doaj.org/article/3ea813e5c9ba4de2bdb3cdf1841757c6
Autor:
Ainhoa Pérez-Díez, Xiangdong Liu, Stephanie Calderon, Ashlynn Bennett, Andrea Lisco, Anela Kellog, Frances Galindo, Matthew J. Memoli, Joseph M. Rocco, Brian P. Epling, Elizabeth Laidlaw, Mike C. Sneller, Maura Manion, Glenn W. Wortmann, Rita Poon, Princy Kumar, Irini Sereti
Publikováno v:
Frontiers in Immunology, Vol 15 (2024)
IntroductionCOVID-19 patients can develop autoantibodies against a variety of secreted and membrane proteins, including some expressed on lymphocytes. However, it is unclear what proportion of patients might develop anti-lymphocyte antibodies (ALAb)
Externí odkaz:
https://doaj.org/article/d8a22ea2cfbd4af099258c951d89ae37
Autor:
Rachel Bean, Luca T. Giurgea, Alison Han, Lindsay Czajkowski, Adriana Cervantes-Medina, Monica Gouzoulis, Allyson Mateja, Sally Hunsberger, Susan Reed, Rani Athota, Holly Ann Baus, John C. Kash, Jaekeun Park, Jeffery K. Taubenberger, Matthew J. Memoli
Publikováno v:
mBio, Vol 15, Iss 2 (2024)
ABSTRACT The induction of systemic antibody titers against hemagglutinin has long been the main focus of influenza vaccination strategies, but mucosal immunity has also been shown to play a key role in the protection against respiratory viruses. By v
Externí odkaz:
https://doaj.org/article/842c7c5ff44f48579058722119124fd8
Autor:
Jennifer A. Croker, Shannon Valenti, Holly Ann Baus, Eric W. Ford, David Mathias, Laurel Yasko, Dan McGaughey, Tony Smith, Katherine Underwood, Jennifer Avolio, Kaitlyn Sadtler, Matthew J. Memoli, Robert P. Kimberly, Steven E. Reis
Publikováno v:
Journal of Clinical and Translational Science, Vol 7 (2023)
As the COVID-19 pandemic took hold in the USA in early 2020, it became clear that knowledge of the prevalence of antibodies to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) among asymptomatic individuals could inform public health poli
Externí odkaz:
https://doaj.org/article/bed6a94cb4fd473f90510e90c2decab0
Publikováno v:
BMC Infectious Diseases, Vol 18, Iss 1, Pp 1-9 (2018)
Abstract Background In clinical studies involving a healthy volunteer human challenge model, a valid and reliable measure to assess the evolution of patient-reported symptom type and severity following viral exposure is necessary. This study examines
Externí odkaz:
https://doaj.org/article/f05b3e9f154840639e9377cf34394f8e
Autor:
Luca T Giurgea, Rachel Bean, Alison Han, Lindsay Czajkowski, Adriana Cervantes-Medina, Monica Gouzoulis, Holly Ann Baus, Susan M Reed, Rani Athota, Allyson Mateja, Sally Hunsberger, John Kash, Jeffery Taubenberger, Matthew J Memoli
Publikováno v:
Open Forum Infectious Diseases. 9
Background In previous influenza challenge studies we observed that the incidence of influenza symptoms was higher in women than in men, and that women experience more symptoms overall. Women also demonstrated lower neuraminidase (NA) inhibition (NAI
Publikováno v:
Vaccines, Vol 8, Iss 3, p 409 (2020)
Neuraminidase (NA) is an influenza surface protein that helps to free viruses from mucin-associated decoy receptors and to facilitate budding from infected cells. Experiments have demonstrated that anti-NA antibodies protect animals against lethal in
Externí odkaz:
https://doaj.org/article/40dc8a15ece34a219a0431f443fdcff4
Autor:
Jennifer A. Croker, Shannon Valenti, Holly Ann Baus, Eric W. Ford, David Mathias, Laurel Yasko, Dan McGaughey, Tony Smith, Katherine Underwood, Jennifer Avolio, Kaitlyn Sadtler, Matthew J. Memoli, Robert P. Kimberly, Steven E. Reis
Publikováno v:
Journal of Clinical and Translational Science. 7
As the COVID-19 pandemic took hold in the USA in early 2020, it became clear that knowledge of the prevalence of antibodies to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) among asymptomatic individuals could inform public health poli
Autor:
Kelly Snead, Vanessa Wall, Carleen Klumpp-Thomas, John-Paul Denson, Heather Kalish, Dominic Esposito, Matthew Drew, Anandakumar Shunmugavel, Jennifer Mehalko, Michael P. Fay, Jennifer L. Hicks, Sam Michael, Matthew D. Hall, Gulcin Gulten, William K. Gillette, Matthew J. Memoli, Sally Hunsberger, Kaitlyn Sadtler, Peter Frank, Min Hong, Simon Messing
Publikováno v:
Nature Communications, Vol 12, Iss 1, Pp 1-13 (2021)
Nature Communications
medRxiv
Nature Communications
medRxiv
The extent of SARS-CoV-2 infection throughout the United States population is currently unknown. High quality serology is a key tool to understanding the spread of infection, immunity against the virus, and correlates of protection. Limited validatio
Autor:
Susan Reed, Adriana Cervantes-Medina, Amy Lwin, Lindsay Czajkowski, Luz Angela Rosas, Rani Athota, Monica Gouzoulis, Jerald C. Sadoff, Sally Hunsberger, Matthew J. Memoli, Holly Ann Baus, Alison Han, Yongli Xiao, Keith Lumbard, Jeffery K. Taubenberger
Publikováno v:
Clin Infect Dis
Background It is imperative to identify new targets for improved vaccines and therapeutics against influenza. One such target is the relatively conserved stalk region of the influenza A hemagglutinin (HA) surface protein. Methods We conducted a rando